As of 2025-05-31, the EV/EBITDA ratio of Yield10 Bioscience Inc (YTEN) is 0.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. YTEN's latest enterprise value is -0.33 mil USD. YTEN's TTM EBITDA according to its financial statements is -12.85 mil USD. Dividing these 2 quantities gives us the above YTEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 13.7x | 13.4x |
| Forward P/E multiples | 17.1x - 31.2x | 19.8x |
| Fair Price | (2,256.88) - (1,802.14) | (2,188.14) |
| Upside | -78464.0% - -62674.4% | -76077.2% |
| Date | EV/EBITDA |
| 2024-11-29 | 0.04 |
| 2024-11-27 | 0.04 |
| 2024-11-26 | 0.04 |
| 2024-11-25 | 0.04 |
| 2024-11-22 | 0.04 |
| 2024-11-21 | 0.04 |
| 2024-11-20 | 0.04 |
| 2024-11-19 | 0.04 |
| 2024-11-18 | 0.04 |
| 2024-11-15 | 0.04 |
| 2024-11-14 | 0.04 |
| 2024-11-13 | 0.04 |
| 2024-11-12 | 0.04 |
| 2024-11-11 | 0.04 |
| 2024-11-08 | 0.04 |
| 2024-11-07 | 0.04 |
| 2024-11-06 | 0.04 |
| 2024-11-05 | 0.04 |
| 2024-11-04 | 0.04 |
| 2024-11-01 | 0.04 |
| 2024-10-31 | 0.04 |
| 2024-10-30 | 0.04 |
| 2024-10-29 | 0.04 |
| 2024-10-28 | 0.04 |
| 2024-10-25 | 0.04 |
| 2024-10-24 | 0.04 |
| 2024-10-23 | 0.04 |
| 2024-10-22 | 0.04 |
| 2024-10-21 | 0.04 |
| 2024-10-18 | 0.04 |
| 2024-10-17 | 0.04 |
| 2024-10-16 | 0.04 |
| 2024-10-15 | 0.04 |
| 2024-10-14 | 0.04 |
| 2024-10-11 | 0.04 |
| 2024-10-10 | 0.04 |
| 2024-10-09 | 0.04 |
| 2024-10-08 | 0.04 |
| 2024-10-07 | 0.04 |
| 2024-10-04 | 0.04 |
| 2024-10-03 | 0.04 |
| 2024-10-02 | 0.04 |
| 2024-10-01 | 0.04 |
| 2024-09-30 | 0.04 |
| 2024-09-27 | 0.04 |
| 2024-09-26 | 0.04 |
| 2024-09-25 | 0.04 |
| 2024-09-24 | 0.04 |
| 2024-09-23 | 0.04 |
| 2024-09-20 | 0.04 |